Timothy Sullivan - Jan 16, 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Chief Financial Officer
Signature: /s/s David Watson, attorney-in-fact for Timothy Sullivan
Stock symbol: APLS
Transactions as of: Jan 16, 2024
Transactions value $: $2,140,221
Form type: 4
Date filed: 1/17/2024, 04:36 PM
Previous filing: Dec 1, 2023
Next filing: Jan 23, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Award	$0	+23.7K	+30.56%	$0.00	101K	Jan 16, 2024	Direct	F1
transaction	APLS	Common Stock	Sale	-$149K	-2.24K	-2.2%	$66.81	99.2K	Jan 16, 2024	Direct	F2
holding	APLS	Common Stock						56.2K	Jan 16, 2024	The Timothy E Sullivan Irrevocable Trust of 2023	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Award	$2.29M	+34.5K		$66.30	34.5K	Jan 16, 2024	Common Stock	34.5K	$66.30	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This represents an award of Restricted Stock Units granted 01/16/2024 that vests annually from grant date over a four year period subject to continued service.
F2	This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/12/2024.
F3	The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
F4	This represents a stock option award granted 01/16/2024 that vests over a four year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.